Pfizer secures FDA approval for Prevnar 20 conjugate vaccine for adults
Prevnar 20 is the first conjugate vaccine approved to protect against 20 types of invasive pneumococcal diseases and…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
09 Jun 21
Prevnar 20 is the first conjugate vaccine approved to protect against 20 types of invasive pneumococcal diseases and…
08 Jun 21
Aduhelm is said to address a defining pathology of Alzheimer’s disease by reducing amyloid beta plaques in the…
07 Jun 21
The Covid-19 vaccine was already approved in the country for use in adults and adolescents aged 16 years…
04 Jun 21
Lynparza showed clinically meaningful improvement in treating gBRCAm, high-risk, HER2-negative early breast cancer, compared to placebo
03 Jun 21
Opdivo plus Yervoy is approved for use in the 27 member states of the European Union (EU), along…
03 Jun 21
The vaccine has been recommended for use in people aged 18 years and above
02 Jun 21
BridgeBio, through its affiliate QED and partner Helsinn, intends to co-commercialise the cholangiocarcinoma drug in the US
31 May 21
MHRA approved Covid-19 Vaccine Janssen after meeting the required safety, quality and effectiveness standards
31 May 21
The EC approval is based on results from the Phase 3 ADAURA trial, in which Tagrisso reduced the…
28 May 21
Zeposia is claimed to be the first and only S1P receptor modulator approved for treating moderately to severely…